Nanoemulsion: A pharmaceutical review

Systematic Reviews in Pharmacy

Volumn 1, Issue 1, 2010, Pages 24-32

  Shah, P ^a   Bhalodia, D ^b   Shelat, P ^b  

^a Saraswati Institute of Pharmaceutical Sciences   (India)

^b K B INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

delivery systems; Nanoemulsion; Neutron Capture Therapy; Self nanoemulsifying drug; Solid self nanoemulsifying drug delivery systems

Indexed keywords

ACECLOFENAC; CAMPTOTHECIN; CELECOXIB; CLARITHROMYCIN; DEXAMETHASONE; DIAZEPAM; DICLOFENAC; DIPALMITOYLPHOSPHATIDYLCHOLINE; DOXORUBICIN; ETOMIDATE; FLURBIPROFEN AXETIL; GADOLINIUM; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; KETOPROFEN; LIMETHASON; LIPOPROSTAGLANDIN E1; METHOHEXITAL; NANOPARTICLE; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; PHOSPHATIDYLCHOLINE; PRIMAQUINE; PRIMROSE OIL; PROPOFOL; PROSTAGLANDIN E1; RISPERIDONE; ROPION; SOYBEAN OIL; TOCOPHEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERY LOW DENSITY LIPOPROTEIN; VITALIPID;

ANTIMICROBIAL ACTIVITY; ARTHRITIS; BLOOD TOXICITY; CREAM; CYTOKINE PRODUCTION; DISPERSION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; GASTROINTESTINAL SYMPTOM; HUMAN; LIPOPHILICITY; MALARIA; MELANOMA; MICROFLUIDIC ANALYSIS; MUCOSAL IMMUNITY; NANOEMULSION; NANOTECHNOLOGY; NEUTRON CAPTURE THERAPY; NONHUMAN; OSTEOARTHRITIS; PATENT; PAW EDEMA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SOFT TISSUE INJURY; SOLID TUMOR; SPRAIN; TERRORISM; THERMODYNAMICS;

EID: 79952491335     PISSN: 09758453     EISSN: 09762779     Source Type: Journal    
DOI: 10.4103/0975-8453.59509     Document Type: Review

References (53)

1. Available from: http://www.azonano.com/. [last updated on 2009 Jul 15]. [Last cited on 2009 Jul 29].
2. Available from: http://www.wikipedia.org/. [last updated on 2009 Jul 25] [last cited on 2009 Aug 2].
3. Solans C, Izquierdo P, Nolla J, Azemar N. Nano-emulsions. Curr Opin Colloid Interface Sci 2005;10:102-10. Available from: http://www.elsevier.com/ locate/cocis. (Pubitemid 41565542)
4. Available from: http://www.nanotech-now.com/. [last updated on 2009 Jul 22]. [Last cited on 2009 Jul 29].
5. Lieberman HA, Rieger MM, Banker GS. Pharmaceutical dosage forms: Disperse systems; Vol. 3, 2 nd ed. Marcel Dekker Inc. p. 339,340,343,344.
6. Lachman L, Lieberman HA, Kanig JL. The Theory and Practice of Industrial Pharmacy; 3 rd ed. p. 510-1.
7. O'Hagan DT. Vaccine Adjuvants. Humana Press; p. 214.
8. Available from: http://www.microfluidicscorp.com/. [last updated on 2009 Aug 2]. [last cited on 2009 Aug 5].
9. Tiwari SB, Amiji MM. Nanoemulsion formulations for tumor-targeted delivery, nanotechnology for cancer therapy. Mansoor M. Amiji, Taylor and Francis Group, editors. 2006. p. 723-39.
10. Available from: http://www.happi.com/. [last updated 2009 Aug 12]. [last cited on 2009 Aug 15].
11. Guglielmini G. Nanostructured novel carrier for topical application. Clin Dermatol 2008; 26:341-6.
12. Available from: http://www.nanobio.com/. [last updated on 2009 Jul 12]. [last cited on 2009 Aug 2].
13. Available from: http://www.usmedicine.com/. [last updated 2009 Aug 12]. [last cited on 2009 Aug 15].
14. Available from: http://www.echoedvoices.org/. [last updated on 2009 Aug 07]. [last cited on 2009 Aug 15]
15. Bielinska AU, Janczak KW, Landers JJ. Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates. AIDS Res Hum Retroviruses 2008;24:271-81. (Pubitemid 351282102)
16. Makidon PE, Bielinska AU, Nigavekar SS, Janczak KW. Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine. PLoS One 2008;3:E2954.
17. Arbor A. Nanoemulsion vaccines show increasing promise Oil-based nasal vaccine technique produces immunity against smallpox, HIV. AIDS Res Hum Retroviruses 2008;24:1-9.
18. Available from: http://www.ewire.com/. [last updated on 2009 Aug 7]. [last cited on 2009 Aug 15].
19. Available from: http://www.infectioncontroltoday.com/. [last updated on 2009 Jul 5]. [last cited on 2009 Aug 12].
20. Available from: http://www.mib-bio.com/. [last updated on 2009 Jul 7]. [last cited on 2009 Aug 15].
21. Ichikawa H, Watanabe T, Tokumitsu H, Fukumori Y. Formulation considerations of gadolinium lipid nanoemulsion for intravenous delivery to tumors in neutron-capture therapy. Curr Drug Deliv 2007;4:131-40. (Pubitemid 46557489)
22. Khandavilli S, Panchagnula R. Nanoemulsions as versatile formulations for paclitaxel delivery: Peroral and dermal delivery studies in rats. J Invest Dermatol 2007;127:154-62. (Pubitemid 46005673)
23. Fang JY, Hung CF, Hua SC, Hwang TL. Acoustically active perfluorocarbon nanoemulsions as drug delivery carriers for camptothecin: Drug release and cytotoxicity against cancer cells. Pharm Res 1998;10:105-11.
24. Kumar M, Misra A, Babbar AK, Mishra AK, Mishra P, Pathak K. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int J Pharm 2008;358:285-91.
25. Constantinide PP, Lambert KJ, Quay SC. Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel. Pharm Res 2000;17:175-82. (Pubitemid 30158366)
26. Eccleston G. Emulsions. Encyclopedia of pharmaceutical technology. In: Swarbrick J, Boylan J, editors. New York: Marcel Dekker; 1992. p. 137-88.
27. Teixeira H, Dubernet C, Chacun H. Cationic emulsions improves the delivery of oligonucleotides to leukemic P388/ADR cells in ascite. J Control Release 2003;89:473-82. (Pubitemid 36555905)
28. Teixeira H, Dubernet C, Puisieux F. Submicron cationic emulsions as a new delivery system for oligonucleotides. Pharm Res 1999;16:30-6. (Pubitemid 29047453)
29. Teixeira H, Dubernet C, Rosilio V, Deverre JR, Scherman D, Benita S. Factors influencing the oligonucleotides release from O-W submicron cationic emulsions. J Control Release 2001;70:243-55. (Pubitemid 32144808)
30. Teixeira H, Rosilio V, Scherman D, Benita S, Couvreur P. Characterization of oligonucleotide/lipid interactions in submicron cationic emulsions: Influence of the cationic lipid structure and the presence of PEG-lipids. Biophys Chem 2001;92:169-81. (Pubitemid 32907297)
31. Waldow SM, Henderson BW. Hyperthermic potentiation of photodynamic therapy employing Photofrin I and II: Comparison of results using three animal tumor models. Lasers Surg Med 1987;7:12-22. (Pubitemid 17038840)
32. Dougherty TJ. Photosensitizers: Therapy and detection of malignant tumors. Photochem Photobiol 1987;45:879-89.
33. Potter WR, Mang TS. The theory of photodynamic therapy dosimetry: Consequences of photo-destruction of sensitizer. Photochem Photobiol 1987;46:97-101.
34. The basics of boron neutron capture therapy. Available from: http://web.mit.edu/nrl/www/bnct/info/description/description.html. [last updated on 2007 Jan 7]. [last cited on 2009 Aug 1].
35. Shawer M, Greenspan P, OIe S. VLDL-resembling phospho lipid-submicron emulsion for cholesterol-based drug targeting. J Pharm Sci 2002;91:1405-13. (Pubitemid 34633956)
36. Teicher BA. Use of perfluorochemical emulsions in cancer therapy. Biomater Artif Cells Immobilization Biotechnol 1992;20:875-82.
37. Teicher BA, Herman TS, Frei E. Perfluorochemical emulsions: Oxygen breathing in radiation sensitization and chemotherapy modulation. Important Adv Oncol 1992:39-59.
38. Teicher BA, Holden SA, Ara G. A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents. J Cancer Res Clin Oncol 1992;118:509-14.
39. Rockwell S, Irvin CG. Effect of a perfluorochemical emulsion on the development of artificial lung metastases in mice. Clin Exp Metastasis 1986;4:45-50. (Pubitemid 16106119)
40. Singh KK, Vingkar SK. Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine. Int J Pharm 2008;347:136-43. (Pubitemid 350180322)
41. Tiwari SB, Shenoy DB. Nanoemulsion Formulations for Improved Oral Delivery of Poorly Soluble Drugs. 9 th Annual NSTI Nanotechnology Conference and Trade Show. Norheastern University. US. 2006.
42. Zlli F, Belser E, Suter F. Preparation and Properties of Coenzyme Q10 Nanoemulsions. CosmeticScience Technology. Available from: http://www.mib-bio. com/. [last cited on 2006].
43. Shakeel F, Baboota S, Shafiq S. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech 2007;8: E104. Available from: http://www.aapspharmscitech.org
44. Kim BS, Won M, Lee KM, Kim CS. in vitro permeation studies of nanoemulsions containing ketoprofen as a model drug. Drug Deliv 2008;15:465-9.
45. Dixit N, Kohli K, Baboota S. Nanoemulsion system for the transdermal delivery of a poorly soluble cardiovascular drug. J Pharm Sci Technol 2008;62:46-55.
46. Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S. Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J Nanobiotechnol 2008;6:8.
47. Rao SV, Shao J. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs I. Formulation development. Int J Pharm 2008;362:2-9.
48. Rao SV, Agarwal P, Shao J. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs II. In vitro transport study. Int J Pharm 2008;362:10-5.
49. Rao SV, Yajurvedi K, Shao J. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs III. In vivo oral absorption study. Int J Pharm 2008;362:16-9.
50. Bansal T, Mustafa G, Khan ZI, Ahmad FJ, Khar RK, Talegaonkar S. Solid self-nanoemulsifying delivery systems as a platform technology for formulation of poorly soluble drugs. Crit Rev Ther Drug Carrier Syst 2008;25:63-116. (Pubitemid 351363757)
51. Available from: http://www.uspto.com/. [last updated on 2009 Jul 30]. [last cited on 2009 Aug 1].
52. Available from: http://www.wipo.org/. [last updated on 2007 Jul 30] [last cited on 2009 Aug 1].
53. Available from: http://www.patentstorm.us/. [last updated on 2007 Jul 29]. [last cited on 2009 Aug 1].